- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Valeant Pharmaceuticals International Inc
+ Add to WatchlistVRX:US
75.3800 USD 2.7900 3.57%As of 20:04:05 ET on 05/20/2013.
Snapshot for Valeant Pharmaceuticals International Inc (VRX)
| Open: | 78.0400 | Day's Range: | 75.1800 - 78.6900 | Volume: | 1,113,303 |
|---|---|---|---|---|---|
| Previous Close: | 78.1700 | 52wk Range: | 42.4700 - 78.6900 | 1-Yr Rtn: | +60.28% |
Key Statistics for VRX
| Current P/E Ratio (ttm) | 62.8167 |
|---|---|
| Estimated P/E(12/2013) | 13.2431 |
| Relative P/E vs. SPX | 3.7814 |
| Earnings Per Share (USD) (ttm) | 1.2000 |
| Est. EPS (USD) (12/2013) | 5.6920 |
| Est. PEG Ratio | 1.1417 |
| Market Cap (M USD) | 22,888.83 |
| Shares Outstanding (M) | 303.65 |
| 30 Day Average Volume | 1,243,446 |
| Price/Book (mrq) | 6.3843 |
| Price/Sale (ttm) | 6.1163 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend (USD) | 1.0000 |
| Last Dividend | 11/10/2010 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for VRX
Company Profile & Key Executives for VRX
Valeant Pharmaceuticals International, Inc. develops and distributes drugs. The Company develops drugs for unmet medical needs in central nervous system disorders, and distributes generic and branded generic drugs in Latin America and Eastern Europe.
| J Michael Pearson "Mike"Chairman/CEO | Michel ChouinardChief Operating Officer |
| Howard B SchillerExec VP/CFO | Ryan H WeldonExec VP/Chair:U.S. Dermatology |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
VRX News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page